Who has invested in Mercy BioAnalytics?

No investors are named on the public record for Mercy BioAnalytics yet.

Mercy BioAnalytics Funding: $100M Raised, Series B (2025)

Mercy BioAnalytics funding overview

Mercy BioAnalytics is a Biotech company based in Natick. Mercy BioAnalytics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2025. The round record for Mercy BioAnalytics runs through 2025; nothing later has been disclosed.

Mercy BioAnalytics at a glance

Total raised: $100M
Latest round: Series B
Latest round date: September 2025
Industry: Biotech
Headquarters: Natick

Frequently asked about Mercy BioAnalytics funding

How much has Mercy BioAnalytics raised?: Mercy BioAnalytics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Mercy BioAnalytics?: No investors are named on the public record for Mercy BioAnalytics yet.
What was the latest Mercy BioAnalytics funding round?: The most recent disclosed round is a Series B, announced in September 2025.
Where is Mercy BioAnalytics based?: Mercy BioAnalytics is based in Natick.
What sector does Mercy BioAnalytics operate in?: Mercy BioAnalytics is tracked under Biotech from Natick, with $100M in disclosed funding.
When did Mercy BioAnalytics last raise?: The last disclosed Mercy BioAnalytics round closed in September 2025 at Series B.

Mercy BioAnalytics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Natick below to benchmark round size and investor mix.

Mercy BioAnalytics Funding: $100M Raised, Series B (2025)

Mercy BioAnalytics funding overview

Mercy BioAnalytics at a glance

Frequently asked about Mercy BioAnalytics funding

Mercy BioAnalytics founders (1)

Companies related to Mercy BioAnalytics (26)

Browse related funding lists (3)